Radiology, Vol 206, 785-790, Copyright © 1998 by Radiological Society of North America

ARTICLES

Localizing prostate cancer in the presence of postbiopsy changes on MR images: role of proton MR spectroscopic imaging

Y Kaji, J Kurhanewicz, H Hricak, DL Sokolov, LR Huang, SJ Nelson and DB Vigneron
Department of Radiology, University of California, San Francisco 94143- 1290, USA.

PURPOSE: To assess whether magnetic resonance (MR) spectroscopic imaging with MR imaging can improve prostate cancer localization in postbiopsy hemorrhage cases. MATERIALS AND METHODS: Records of 175 patients with prostate cancer were retrospectively reviewed; 42 patients (135 hemorrhagic sites) had spatially correlated biopsy data. Patients underwent both phased-array coil-endorectal coil MR imaging and three-dimensional MR spectroscopic imaging within 180 days after transrectal ultrasound (US)-guided biopsy. High-signal-intensity hemorrhage on T1-weighted images and corresponding high- or low-signal- intensity areas on T2-weighted images and the metabolic ratio (choline + creatine)/citrate were recorded. Cancer was identified as a low- signal-intensity area at T2-weighted MR imaging or a metabolite ratio greater than 3 standard deviations above normal at MR spectroscopic imaging. MR imaging, spectroscopic, and biopsy findings were compared. RESULTS: Forty-nine patients had postbiopsy hemorrhage. On T2-weighted images, a higher (P < .01) percentage of hemorrhagic sites demonstrated low signal intensity (80% [108 of 135 sites]), which is similar to the signal intensity seen with cancer. The addition of MR spectroscopic imaging to MR imaging resulted in a significant increase (P < .01) in the accuracy (52% to 75%) and specificity (26% to 66%) of tumor detection. CONCLUSION: The addition of MR spectroscopic imaging to MR imaging significantly improves the ability to determine the presence of prostate cancer and spatial extent when postbiopsy changes hinder interpretation with MR imaging alone.

This article has been cited by other articles:

				T. Tamada, T. Sone, Y. Jo, A. Yamamoto, T. Yamashita, N. Egashira, S. Imai, and M. Fukunaga Prostate Cancer: Relationships between Postbiopsy Hemorrhage and Tumor Detectability at MR Diagnosis Radiology, August 1, 2008; 248(2): 531 - 539. [Abstract] [Full Text] [PDF]

				A. Graser, A. Heuck, B. Sommer, J. Massmann, J. Scheidler, M. Reiser, and U. Mueller-Lisse Per-Sextant Localization and Staging of Prostate Cancer: Correlation of Imaging Findings with Whole-Mount Step Section Histopathology Am. J. Roentgenol., January 1, 2007; 188(1): 84 - 90. [Abstract] [Full Text] [PDF]

				Y. J. Choi, J. K. Kim, N. Kim, K. W. Kim, E. K. Choi, and K.-S. Cho Functional MR Imaging of Prostate Cancer RadioGraphics, January 1, 2007; 27(1): 63 - 75. [Abstract] [Full Text] [PDF]

				J. A. Jung, F. V. Coakley, D. B. Vigneron, M. G. Swanson, A. Qayyum, V. Weinberg, K. D. Jones, P. R. Carroll, and J. Kurhanewicz Prostate Depiction at Endorectal MR Spectroscopic Imaging: Investigation of a Standardized Evaluation System Radiology, December 1, 2004; 233(3): 701 - 708. [Abstract] [Full Text] [PDF]

				J. P. Dyke, K. L. Zakian, W. M. Spees, C. Matei, Y. Chen, X. Mao, D. C. Shungu, and J. A. Koutcher Metabolic Response of the CWR22 Prostate Tumor Xenograft after 20 Gy of Radiation Studied by 1H Spectroscopic Imaging Clin. Cancer Res., October 1, 2003; 9(12): 4529 - 4536. [Abstract] [Full Text] [PDF]

				K. L. Zakian, S. Eberhardt, H. Hricak, A. Shukla-Dave, S. Kleinman, M. Muruganandham, K. Sircar, M. W. Kattan, V. E. Reuter, P. T. Scardino, et al. Transition Zone Prostate Cancer: Metabolic Characteristics at H MR Spectroscopic Imaging--Initial Results Radiology, October 1, 2003; 229(1): 241 - 247. [Abstract] [Full Text] [PDF]

				H Ito, K Kamoi, K Yokoyama, K Yamada, and T Nishimura Visualization of prostate cancer using dynamic contrast-enhanced MRI: comparison with transrectal power Doppler ultrasound Br. J. Radiol., September 1, 2003; 76(909): 617 - 624. [Abstract] [Full Text] [PDF]

				J. R. Thornbury, D. K. Ornstein, P. L. Choyke, C. P. Langlotz, and J. C. Weinreb Prostate Cancer: What Is the Future Role for Imaging? Am. J. Roentgenol., January 1, 2001; 176(1): 17 - 22. [Full Text]

				M. van der Graaf, H. J. van den Boogert, G. J. Jager, J. O. Barentsz, and A. Heerschap Human Prostate: Multisection Proton MR Spectroscopic Imaging with a Single Spin-Echo Sequence-Preliminary Experience Radiology, December 1, 1999; 213(3): 919 - 925. [Abstract] [Full Text]

				K. K. Yu, J. Scheidler, H. Hricak, D. B. Vigneron, C. J. Zaloudek, R. G. Males, S. J. Nelson, P. R. Carroll, and J. Kurhanewicz Prostate Cancer: Prediction of Extracapsular Extension with Endorectal MR Imaging and Three-dimensional Proton MR Spectroscopic Imaging Radiology, November 1, 1999; 213(2): 481 - 488. [Abstract] [Full Text]